The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting CD47 in lymphoid malignancies with CAR T cells.
 
Alexander Paul Boardman
No Relationships to Disclose
 
Scott James
Patents, Royalties, Other Intellectual Property - Pending patents related to leucine zipper sorting technology
 
Marcel R. M. Van Den Brink
Honoraria - BeiGene (I); Ceramedix; Da Volterra; Forty Seven; Frazier Healthcare Partners; GlaxoSmithKline; Lygenesis; Magenta Therapeutics; Merck; Nektar; Notch Therapeutics; Novartis (I); Pluto Immunotherapeutics; Priothera; Rheos Medicines; Seres Therapeutics; Synthekine (I); WindMIL; WindMIL
Consulting or Advisory Role - Seres Therapeutics
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - Dr. van den Brink receives royalties from Wolters Kluwer, and he has intellectual property Licensing with Seres Therapeutics and Juno Therapeutics
Travel, Accommodations, Expenses - Rheos Medicines
Other Relationship - DKMS
(OPTIONAL) Uncompensated Relationships - Notch Therapeutics; Pluto Immunotherapeutics; Seres therapeutics